Veradigm Inc. (NASDAQ:MDRX – Get Free Report)’s stock price gapped up before the market opened on Tuesday . The stock had previously closed at $9.51, but opened at $9.75. Veradigm shares last traded at $9.55, with a volume of 338,492 shares traded.
Wall Street Analyst Weigh In
MDRX has been the topic of several research reports. TD Cowen reduced their price objective on Veradigm from $26.00 to $15.00 and set a “buy” rating on the stock in a report on Tuesday, May 28th. StockNews.com assumed coverage on Veradigm in a report on Wednesday. They set a “hold” rating on the stock. Four equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, Veradigm currently has an average rating of “Hold” and a consensus target price of $12.00.
Get Our Latest Analysis on MDRX
Veradigm Price Performance
Institutional Inflows and Outflows
A number of large investors have recently made changes to their positions in the stock. Vanguard Group Inc. increased its position in shares of Veradigm by 0.7% in the 4th quarter. Vanguard Group Inc. now owns 14,275,875 shares of the software maker’s stock valued at $149,754,000 after buying an additional 95,291 shares in the last quarter. Wellington Management Group LLP increased its position in shares of Veradigm by 117.8% in the 4th quarter. Wellington Management Group LLP now owns 5,806,297 shares of the software maker’s stock valued at $60,908,000 after buying an additional 3,140,483 shares in the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of Veradigm by 8.9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,087,605 shares of the software maker’s stock valued at $21,899,000 after buying an additional 171,199 shares in the last quarter. Goldman Sachs Group Inc. increased its position in shares of Veradigm by 6.6% in the 4th quarter. Goldman Sachs Group Inc. now owns 1,596,684 shares of the software maker’s stock valued at $16,749,000 after buying an additional 99,528 shares in the last quarter. Finally, Tyro Capital Management LLC bought a new stake in shares of Veradigm in the 1st quarter valued at $9,055,000.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- How to Evaluate a Stock Before Buying
- Target Hits the Mark: Q2 Earnings Exceed Expectations
- What Does Downgrade Mean in Investing?
- Is Tesla’s Rebound Just Starting? Why You Should Consider Buying
- Financial Services Stocks Investing
- Stanley Druckenmiller’s Latest Bet: MELI—Should You Follow Suit?
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.